Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evolution of CMV Antiviral T-cell Immunity Over the Next Six Months Initiation of Treatment With Belatacept.

NCT05708534 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT05708534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05708534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evolution of CMV Antiviral T-cell Immunity Over the Next Six Months Initiation of Treatment With Belatacept.
Lead sponsor
University Hospital, Rouen
Phase
Observational
Overall status
Active, not recruiting
Start date
November 14, 2023
Completion date
May 31, 2027
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant infection